Status:
COMPLETED
Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)
Lead Sponsor:
German Cancer Research Center
Collaborating Sponsors:
Mukoviszidose Institut gGmbH
Heidelberg University
Conditions:
Cystic Fibrosis
Lung Disease
Eligibility:
All Genders
1-6 years
Brief Summary
In patients with Cystic Fibrosis (CF) the clinical course of lung disease is crucial for individual prognosis and life expectancy. Imaging modalities are important in the assessment of follow up of s...
Detailed Description
Month 1-2: Protocol adaptation for infants and small children Month 3-14: Patient examinations (20 Patients with sedation) Month 15-18: Data evaluation
Eligibility Criteria
Inclusion
- Informed consent signed by the parents or a legal guardian
- Sedation as necessary
- Conventional clinical indicated diagnostic procedures (lung function test, chest-X-ray, CT)
Exclusion
- Study exclusion in case of contra indications for MRI:
- Patients with cardiac pace maker, metallic implants (e.g. cerebral vessel clips) as well as other conditions that prohibit the exposition of a patient to a strong magnetic field.
- No informed consent
- Dyspnea, which disables the patient to follow breathing instructions during the study.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00760071
Start Date
July 1 2006
End Date
September 1 2009
Last Update
April 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
German Cancer Research Center
Heidelberg, Germany, 69120